Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia.
Chihanga, T; Vicente-Muñoz, S; Ruiz-Torres, S; Pal, B; Sertorio, M; Andreassen, PR; Khoury, R; Mehta, P; Davies, SM; Lane, AN; et al.
Cancers.
2022;
14.
Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series.
Edwards, A; Teusink-Cross, A; Martin, LJ; Prows, CA; Mehta, PA; Ramsey, LB.
Clinical and Translational Science.
2022;
15:610-618.
Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults.
Wang, YZ M; Teusink-Cross, A; Elborai, Y; Krupski, MC; Nelson, AS; Grimley, MS; Flannery, A; Mehta, PA; Bleesing, JJ; Chandra, S; et al.
Transplantation.
2022;
106:412-419.
Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disorders.
Chandra, S; Mizuno, K; Zhao, J; Davies, SM; Marsh, RA; Fukuda, T; Setchell, KD R; Vinks, AA; Mehta, PA.
British Journal of Clinical Pharmacology.
2022;
88:115-127.
Model-informed precision dosing for alemtuzumab in paediatric and young adult patients undergoing allogeneic haematopoietic cell transplantation.
Dong, M; Emoto, C; Fukuda, T; Arnold, DE; Mehta, PA; Marsh, RA; Vinks, AA.
British Journal of Clinical Pharmacology.
2022;
88:248-259.
Modern Lung Magnetic Resonance Imaging to Screen for Pulmonary Complications in Patients with Dyskeratosis Congenita.
Walkup, LL; Myers, KC; Willmering, MM; Mehta, PA; Nelson, AS; Fleck, RJ; Woods, JC; Davies, SM; Towe, CT.
American Journal of Respiratory and Critical Care Medicine.
2021;
204:1340-1343.